Phase 1 Trial of Oral Ixabepilone

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Advanced Solid Tumors

Interventions

DRUG

Ixabepilone (oral formulation)

Capsules, Oral, Dose escalating (Phase 1), 3 doses on 1 day every 3 weeks, until disease progression or unacceptable toxicity

Trial Locations (2)

Georgetown University Medical Center, Washington D.C.

Stanford University, Stanford